METHODS: In this study, we evaluated 194 patients with chronic cough. No subject had received any anti-inflammatory treatment before clinical evaluation, and none was an active smoker. ECP was measured with a commercially available fluoroenzyme immunoassay and results were expressed as µg/L.
RESULTS: The analysis of variance showed that mean ECP level differs among the various diagnosis categories (P<0.001). Mean ECP level was significantly higher in asthmatic patients, particularly in the active disease.
CONCLUSIONS: Serum ECP concentration could represent a useful biomarker in the clinical work-up of chronic cough, managing to differentiate asthma from other chronic disorders.
方法:在本研究中,我们评估了194例慢性咳嗽患者.在临床评估之前,没有受试者接受过任何抗炎治疗,没有一个是活跃的吸烟者。用市售的荧光酶免疫测定法测定ECP,结果以µg/L表示。
结果:方差分析显示不同诊断类别的平均ECP水平不同(P<0.001)。哮喘患者的平均ECP水平明显更高,特别是在活动性疾病中。
结论:血清ECP浓度可能是慢性咳嗽临床检查中有用的生物标志物,设法将哮喘与其他慢性疾病区分开来。